The SCONE™ reduces the risk of infectious aerosol exposure to health care workers using negative pressure technology by creating "active" barrier protection that maximizes hospital throughput and improves the quality of patient care.
FDA EUA APPROVED COVID-19 MEDICAL DEVICE
The SCONE™ will be the first American-made, single-use, disposable negative pressure device pending authorization for emergency use (EUA) by the FDA for “active” barrier protection in hospital settings. In pre-clinical testing, the SCONE™ achieved a clearance rate of 5 minutes under expected operating conditions.
Reduce Exposure Risk to Health Care Workers
Keep your HCWs safe and healthy by implementing SCONE™ protocols as a modern safety strategy to protect against virus aerosols and droplets.
Reduce Demand for PPE and Ventilators
Potentially reduce PPE changes on room entry/exit and return to “universal precaution” standards. Use isolated HF-NC/BiPAP/CPAP to reduce the risk of early intubation.
Family Visits and End of Life Care
Boost patient and family morale and meet patient emotional support needs by adding SCONE™ to your hospital guidelines for safe visitation protocols.
Maximize Throughput, Improve Patient Flow
Triage patients efficiently and prevent bottlenecking in isolation rooms. Keep environmental air safe during transport of patients in and through the hospital.
“The SCONE™ achieved high level control of virus-sized aerosols under expected operating conditions...with a 99% clearance rate within 5 minutes." - Dr. Michael Wallace, Mayo Clinic
